UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002740
Receipt number R000003332
Scientific Title Mycophenolate mofetil treatment for steroid resistant nephrotic syndrome
Date of disclosure of the study information 2009/11/15
Last modified on 2012/08/11 18:35:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Mycophenolate mofetil treatment for steroid resistant nephrotic syndrome

Acronym

Mycophenolate mofetil treatment for steroid resistant nephrotic syndrome

Scientific Title

Mycophenolate mofetil treatment for steroid resistant nephrotic syndrome

Scientific Title:Acronym

Mycophenolate mofetil treatment for steroid resistant nephrotic syndrome

Region

Japan


Condition

Condition

steroid resistant nephrotic syndrome

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We evaluate the efficacy of mycophenolate mofetil treatment for a patient with steroid resistant nephrotic syndrome.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

remission

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Mycophenolate mofetil (Cellcept 250mg capsule) 3 to 4 capsule a day.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

18 years-old >=

Gender

Female

Key inclusion criteria

steroid resistant nephrotic syndrome ( no responder who treated with prednisolone 2 mg/kg/day or 60 mg/m2/day for 4 weeks)

Key exclusion criteria

No exclusion criteria

Target sample size

1


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Fumio Endo

Organization

Kumamoto University, Faculty of Medical and Pharmaceutical Sciences

Division name

Department of Pediatrics

Zip code


Address

1-1-1 Honjo, Kumamoto 860-8556, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Hitoshi Nakazato

Organization

Kumamoto University, Faculty of Medical and Pharmaceutical Sciences

Division name

Department of Pediatrics

Zip code


Address

1-1-1 Honjo, Kumamoto 860-8556, Japan

TEL

096-373-5191

Homepage URL


Email

hnakazat@fc.kuh.kumamoto-u.ac.jp


Sponsor or person

Institute

Kumamoto University, Department of Pediatrics

Institute

Department

Personal name



Funding Source

Organization

patient

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

熊本大学病院(熊本県)、熊本中央病院(熊本県)


Other administrative information

Date of disclosure of the study information

2009 Year 11 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2009 Year 11 Month 05 Day

Date of IRB


Anticipated trial start date

2009 Year 11 Month 01 Day

Last follow-up date

2011 Year 12 Month 01 Day

Date of closure to data entry

2011 Year 12 Month 01 Day

Date trial data considered complete

2011 Year 12 Month 01 Day

Date analysis concluded

2012 Year 08 Month 11 Day


Other

Other related information



Management information

Registered date

2009 Year 11 Month 10 Day

Last modified on

2012 Year 08 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003332


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name